Rank/Rankl/opg: literature review

The discovery of the receptor activator of nuclear factor-kB (RANK)/RANK Ligand (RANKL)/osteoprotegerin (OPG) pathway contributed to the understanding of how bone formation and resorption were processed and regulated. RANKL and OPG are members of the tumor necrosis factor (TNF) and TNF receptor (TNF...

Full description

Bibliographic Details
Main Author: Silva, I (author)
Other Authors: Branco, Jaime (author)
Format: review
Language:eng
Published: 2017
Subjects:
Bone Formation
SYNOVIAL TISSUE
BREAST-TUMORS
Osteoprotegerin
OPG EXPRESSION
RECEPTOR ACTIVATOR
BONE-MINERAL DENSITY
RHEUMATOID-ARTHRITIS
RANK
KAPPA-B LIGAND
Osteoclast
OSTEOPROTEGERIN EXPRESSION
RANKL
POSTMENOPAUSAL WOMEN
OSTEOCLAST DIFFERENTIATION
Bone Formation.
Online Access:http://hdl.handle.net/10362/22008
Country:Portugal
Oai:oai:run.unl.pt:10362/22008

Internet

http://hdl.handle.net/10362/22008

Similar Items